Efficacy and Safety of QiShen YiQi Dripping Pills in the Treatment of Diabetic Kidney Disease (Syndrome of Qi Deficiency With Blood Stasis)
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 228 participants.
Also called NCT06006689
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 228 participants
- Registry
-
NCT06006689
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT06006689. Randomized; quadruple masking; primary purpose treatment. Start 2023-09-15 (actual); primary completion 2025-04-16 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety of QiShen YiQi Dripping Pills in the Treatment of Diabetic Kidney Disease (Syndrome of Qi Deficiency With Blood Stasis)
- Condition
- Diabetic Kidney Disease
- Intervention (Drug)
- Qishen Yiqi Dripping Pills placebo 3 bags
- Intervention (Drug)
- Low dose Qishen Yiqi Dripping Pills 3 bags
- Intervention (Drug)
- High dose Qishen Yiqi Dripping Pills 3 bags
- Lead sponsor
- Tasly Pharmaceutical Group Co., Ltd
Record details
- Record id
cardio:ct-nct06006689- Content hash
8ef43fc8d0810c568bc6e9a8dff439f7b7fcb43690ee4941c2a08718ebea8498